Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    SELLAS Life Sciences Grou...

    NASDAQ: SLS · Real-Time Price · USD
    1.60
    -0.03 (-1.84%)
    At close: Jun 06, 2025, 3:59 PM
    1.63
    1.56%
    After-hours: Jun 06, 2025, 05:57 PM EDT

    SELLAS Life Sciences Statistics

    Share Statistics

    SELLAS Life Sciences has 99.78M shares outstanding. The number of shares has increased by 57.3% in one year.

    Shares Outstanding

    n/a
    		 99.78M

    Shares Change (YoY)

    n/a
    		 57.3%

    Shares Change (QoQ)

    n/a
    		 29.08%

    Owned by Institutions (%)

    n/a
    		 9.95%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 625

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 8.76M, so 8.78% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.76M

    Short % of Shares Out

    n/a
    		 8.78%

    Short % of Float

    n/a
    		 8.87%

    Short Ratio (days to cover)

    n/a
    		 3.34

    Valuation Ratios

    The PE ratio is -20.61 and the forward PE ratio is -4.18. SELLAS Life Sciences's PEG ratio is 0.31.

    PE Ratio

    n/a
    		 -20.61

    Forward PE

    n/a
    		 -4.18

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 67.25

    P/FCF Ratio

    n/a
    		 -17.98

    PEG Ratio

    n/a
    		 0.31
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for SELLAS Life Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.11.

    Current Ratio

    n/a
    		 1.72

    Quick Ratio

    n/a
    		 1.72

    Debt / Equity

    n/a
    		 0.11

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,058,733.33

    Employee Count

    n/a
    		 15

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 10.2% in the last 52 weeks. The beta is 2.27, so SELLAS Life Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.27

    52-Week Price Change

    n/a
    		 10.2%

    50-Day Moving Average

    n/a
    		 1.45

    200-Day Moving Average

    n/a
    		 1.25

    Relative Strength Index (RSI)

    n/a
    		 50.43

    Average Volume (20 Days)

    n/a
    		 1,861,669

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -31.51M

    Net Income

    n/a
    		 -30.88M

    EBITDA

    n/a
    		 -30.88M

    EBIT

    n/a
    		 -30.88M

    Earnings Per Share (EPS)

    n/a
    		 -0.05
    Full Income Statement

    Balance Sheet

    The company has 13.99M in cash and 1M in debt, giving a net cash position of 12.98M.

    Cash & Cash Equivalents

    n/a
    		 13.99M

    Total Debt

    n/a
    		 1M

    Net Cash

    n/a
    		 12.98M

    Retained Earnings

    n/a
    		 -248.13M

    Total Assets

    n/a
    		 34.96M

    Working Capital

    n/a
    		 25.09M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -35.4M and capital expenditures 0, giving a free cash flow of -35.4M.

    Operating Cash Flow

    n/a
    		 -35.4M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -35.4M

    FCF Per Share

    n/a
    		 -0.06
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SLS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for SLS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 8, 2019. It was a backward split with a ratio of 1:50.

    Last Split Date

    n/a
    		 Nov 8, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:50

    Scores

    Altman Z-Score

    n/a
    		 3.19

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist